EMPIRICO
LIVE

Serial Number

98151684

Owner

Empirico Inc.

Attorney

Chelsea E. Carbone

Filing Date

Aug 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EMPIRICO Trademark

Serial Number: 98151684

EMPIRICO is a trademark filed by Empirico Inc. on August 25, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Empirico Inc. (3 trademarks)

4660 La Jolla Village Drive, Suite 100
San Diego, CA 92122

Entity Type: 03

Trademark Details

Filing Date

August 25, 2023

Registration Date

Not Registered

Published for Opposition

August 27, 2024

Goods & Services

Pharmaceutical preparations for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal and digestive system, diseases of aging, diseases of the blood, diseases of the brain, diseases of the ear, nose and throat, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, diseases of pregnancy, psychiatric diseases, nutritional diseases, hereditary diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in angiology, cardiology, endocrinology, gastroenterology, genetics, geriatrics, gynecology, hematology, hepatology, immunology, nephrology, neurology, obstetrics, oncology, pulmonology, pneumology, respirology, rheumatology, anesthesiology, urology, dermatology, gynecology, orthopedics, ophthalmology, infectiology, and psychiatry, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal and digestive system, diseases of aging, diseases of the blood, diseases of the brain, diseases of the ear, nose and throat, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, diseases of pregnancy, psychiatric diseases, nutritional diseases, hereditary diseases, allergic diseases and infectious diseases; pharmaceutical preparations for use in pediatric, adolescent, adult, geriatric, inpatient, outpatient, acute, emergency, family, and preventative medicine, particularly for preventing or treating diseases of the cardiovascular system, diseases of the endocrine system, diseases of the gastrointestinal and digestive system, diseases of aging, diseases of the blood, diseases of the brain, diseases of the ear, nose and throat, diseases of the liver, diseases of the kidney, diseases of the nervous system, cancer, metabolic diseases, diseases of the immune system, diseases of the respiratory system, diseases of the musculoskeletal system, diseases of the genitourinary system, diseases of the skin, diseases of the eye, diseases of the auditory system, diseases of the reproductive system, diseases of pregnancy, psychiatric diseases, nutritional diseases, hereditary diseases, allergic diseases and infectious diseases; pharmaceutical preparations for the treatment of infectious, deficiency, excess, acquired, idiopathic, iatrogenic, genetic, hereditary, and physiological diseases

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 28, 2026 EXRA
SOU EXTENSION 3 GRANTED
Mar 27, 2026 EX3G
SOU EXTENSION 3 FILED
Mar 27, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Mar 27, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 9, 2025 EXRA
SOU EXTENSION 2 GRANTED
Oct 9, 2025 EX2G
SOU EXTENSION 2 FILED
Oct 8, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 8, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 20, 2025 EXRA
SOU EXTENSION 1 GRANTED
Mar 20, 2025 EX1G
SOU EXTENSION 1 FILED
Mar 19, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 19, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 22, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 25, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 24, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 26, 2024 GNRN
NON-FINAL ACTION E-MAILED
Apr 26, 2024 GNRT
NON-FINAL ACTION WRITTEN
Apr 26, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 25, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 26, 2023 NWOS
NEW APPLICATION ENTERED
Aug 29, 2023 NWAP